Nowak N M, Fischer O M, Gust T C, Fuhrmann U, Habenicht U-F, Schmidt A
GDD-TRG Women's Healthcare, Bayer Schering Pharma AG, Berlin, Germany.
Hum Reprod. 2008 Nov;23(11):2466-74. doi: 10.1093/humrep/den189. Epub 2008 Jul 24.
The role of the immune system in the pathogenesis of endometriosis remains elusive. It has been shown that patients have an altered peritoneal environment with increased levels of inflammatory cytokines, activated macrophages and reduced clearance of retrogradely transported endometrial fragments. However, it is not known if this unique inflammatory situation is cause or consequence of endometriosis. This study investigates the impact of a pre-existing peritoneal inflammation on endometriosis establishment in a mouse model.
Endometriosis was induced by intraperitoneal injection of enhanced green fluorescent protein (EGFP)-expressing endometrium in mice. In parallel, a peritonitis model was established via intraperitoneal injection of thioglycolate medium (TM). Finally, endometriosis was induced in the inflamed peritoneal cavity and lesion establishment as well as morphological and histological characteristics were analysed.
Induction of endometriosis in an inflamed peritoneal cavity resulted in fewer lesions and significantly lower sum of lesion surface area per mouse in the TM-treated group. Additionally, a higher amount of non-attached debris could be detected in the peritoneal cavity of TM-treated mice.
An intraperitoneal inflammation decreases endometriosis establishment in this mouse model. Thus, a pre-existing peritoneal inflammation might not be a factor favouring the development of endometriosis.
免疫系统在子宫内膜异位症发病机制中的作用仍不明确。研究表明,子宫内膜异位症患者的腹膜环境发生改变,炎症细胞因子水平升高,巨噬细胞活化,逆行转运的子宫内膜碎片清除减少。然而,这种独特的炎症状态是子宫内膜异位症的病因还是结果尚不清楚。本研究在小鼠模型中探讨了预先存在的腹膜炎症对子宫内膜异位症形成的影响。
通过向小鼠腹腔内注射表达增强型绿色荧光蛋白(EGFP)的子宫内膜来诱导子宫内膜异位症。同时,通过腹腔注射巯基乙酸盐培养基(TM)建立腹膜炎模型。最后,在炎症性腹腔内诱导子宫内膜异位症,并分析病变形成以及形态学和组织学特征。
在炎症性腹腔内诱导子宫内膜异位症,TM处理组的病变较少,每只小鼠的病变表面积总和显著降低。此外,在TM处理的小鼠腹腔中可检测到更多的非附着碎片。
在该小鼠模型中,腹腔炎症可减少子宫内膜异位症的形成。因此,预先存在的腹膜炎症可能不是促进子宫内膜异位症发展的因素。